• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during pregnancy and nursing is challenging for women with the condition. There are few data on how long-term exposure may affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should weigh the benefits of taking it against the possible risks to the fetus. Physicians don't have the data to provide clear recommendations but they can provide information on risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy were not at a greater risk of fetal malformations or structural birth defects. Researchers conducted a large, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists examined the cases to ensure accurate case classification and to minimize the chance of bias.

The study of the researchers was not without limitations. Most important, they were unable to separate the effects of the medication from those of the underlying disorder. This makes it difficult to know whether the limited associations observed in the exposed groups are due to medication use or the confounding effect of comorbidities. The researchers did not study long-term outcomes for the offspring.

The study showed that babies whose mothers took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) as compared to mothers who did not take any medication during pregnancy or had discontinued taking their medication for odd and Adhd prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an elevated risk of having a caesarean birth or having a baby with a low Apgar score (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages may be offset by the greater benefits for baby and mother of continued treatment for the woman’s disorder. Physicians should speak with their patients about this issue and as much as possible, assist them improve coping skills which may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

Doctors are increasingly faced with the decision of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of solid and reliable evidence in either case, which means that doctors have to weigh their experience, the experiences of other doctors, and what the research says on the topic as well as their own best adhd medication uk judgment for each individual patient.

The issue of risk for infants can be particularly tricky. The research on this subject is based on observations instead of controlled studies and the results are conflicting. In addition, most studies limit their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have found a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no connection and the majority of studies have a neutral or slight negative effect. In all cases, a careful analysis of the benefits and risks is required.

For women suffering from ADHD and ADD, the decision to stop medication is difficult if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. In addition, a decrease in medication can affect the ability to do jobs and drive safely that are crucial aspects of daily life for many people with ADHD.

She recommends women who are unsure about whether to continue or discontinue medication due to their pregnancy, consider informing family members, friends and colleagues about the condition, its effects on daily functioning, and on the benefits of keeping the current treatment plan. It can also help a woman feel supported in her decision. It is also worth noting that some drugs can be absorbed through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug could be passed on to the baby.

Risk of Birth Defects

As the use and misuse of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing, so does concern about the possible effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two huge data sets to study more than 4.3 million pregnancy and determine if stimulant medication use increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher rates of certain heart defects, such as ventriculoseptal defect.

The researchers of the study could not discover any link between the use of early medications and other congenital anomalies such as facial deformities or club feet. The results are consistent with previous studies revealing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. This risk increased in the later part of pregnancy, when a lot of women decide to stop taking their adult adhd medication uk medication.

Women who took ADHD medications in the first trimester of their pregnancies were also more likely to undergo a caesarean section, a low Apgar score after delivery and a baby who needed breathing assistance during birth. However the researchers of the study were unable to eliminate selection bias by restricting the study to women who didn't have other medical issues that could have contributed to these findings.

The researchers hope their research will aid in the clinical decisions of doctors who see pregnant women. They recommend that, while discussing the risks and benefits is crucial, the decision to stop or continue treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors warn that, although stopping the medication is a possibility to look into, it is not recommended due to the high prevalence of depression and mental health issues for women who are pregnant or who have recently given birth. Further, research shows that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women suffering from adhd medication Names are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. Therefore, many women decide to continue taking their ADHD medications throughout pregnancy.

The risk for nursing infant is low because the majority of stimulant medication passes through breast milk in low amounts. However, the rate of medication exposure to the newborn can vary depending on dosage, how often it is administered, and the time of the day it is administered. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not well understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult decision for the patient, who must weigh the benefits of continuing her medication against the possible risks to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients whether they have any history of ADHD or if they intend to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. As a result, more and more patients choose to do so, and in consultation with their doctor they have discovered that the benefits of keeping their current medication far exceed any risk.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and ADHD Medication List discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also required to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should be a multidisciplinary effort including obstetricians, GPs and psychiatry. The pregnancy counselling should consist of discussion of a management plan for both mother and child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.